Page last updated: 2024-11-06

prednisolone and Craniofacial Abnormalities

prednisolone has been researched along with Craniofacial Abnormalities in 1 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Craniofacial Abnormalities: Congenital structural deformities, malformations, or other abnormalities of the cranium and facial bones.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanigawa, T1
Tanaka, H1
Sato, T1
Banno, S1
Kishimoto, M1
Brodie, H1
Ueda, H1

Other Studies

1 other study available for prednisolone and Craniofacial Abnormalities

ArticleYear
Craniometaphyseal dysplasia unnoticed until 19 years of age: First diagnosed from facial nerve paralysis.
    Auris, nasus, larynx, 2011, Volume: 38, Issue:3

    Topics: Anti-Inflammatory Agents; Bone Diseases, Developmental; Craniofacial Abnormalities; Delayed Diagnosi

2011